1. Introduction {#sec1}
===============

Pirfenidone (PFD, Esbriet®, 5-methyl-1-phenylpyridin-2\[H-1\]-one), a pyridone derivative, is thought to act by interfering with the production of transforming growth factor-β and tumor necrosis factor-α([@bib3]; [@bib38]). This compound is a new anti-fibrotic drug approved by the U.S. Food and Drug Administration for idiopathic pulmonary fibrosis. Accumulating evidence has revealed the efficacy of PFD either in treating idiopathic pulmonary fibrosis ([@bib4]; [@bib38]), in interstitial lung disease ([@bib12]), or in non-small cell lung cancer ([@bib23]; [@bib25]). Recently, through its anti-inflammatory and anti-oxidant effects, namely by inhibiting IL-1β and IL-4, PFD has been included in a clinical trial for the treatment of *coronavirus* disease (*COVID*-19) ([@bib1]; [@bib37]).

In addition to its demonstrated activity in idiopathic pulmonary fibrosis, PFD has been also reported to attenuate neuronal loss and reduce lipid peroxidation in the pubescent rat hippocampus ([@bib8]), as well as to diminish cerebral ischemia-reperfusion injury ([@bib33]). Moreover, in cardiac myocytes, PFD has been shown to influence increased the amplitude of L-type Ca^2+^ current ([@bib35]). However, until now, whether or how this drug can perturb different types of membrane ionic currents in electrically excitable cells is still poorly understood.

The magnitude of hyperpolarization-activated cation current (*I* ~h~ or funny current \[*I* ~f~\]) has been considered to be the notable determinant of repetitive electrical activities inherently in cardiac cells and various electrically excitable cells ([@bib14]). This type of ionic current is characterized by a mixed inward Na^+^/K^+^ one with a slowly activating property during long-lasting membrane hyperpolarization, and it is subject either to inhibition by various compounds, such as CsCl, ivabradine, zatebradine or *ent*-kaurane-type diterpenoids, or to stimulation by oxaliplatin ([@bib14]; [@bib43]; [@bib45]).

As described previously ([@bib9]; [@bib21]; [@bib42]), the increased amplitude of *I* ~h~ can depolarize membrane potential to the threshold required for action potential elicitation in electrically excitable cells. The *I* ~h~ has been observed to be carried by channels of the hyperpolarization-activated cyclic nucleotide-gated (HCN1-4) gene family, a member of cyclic nucleotide-gated and voltage-gated K^+^ channels ([@bib11]; [@bib14]). However, to the best of our knowledge, limited information regarding effects of PFD on the biophysical and pharmacological properties of *I* ~h~ has been reported.

Therefore, in light of the considerations described above, the current study wanted to explore whether PFD is capable of interacting with HCNx channels to perturb any modifications on *I* ~h~ in a concentration- and state-dependent fashion and to determine whether this compound exerts any perturbations on different types of K^+^ currents (e.g., M-type K^+^ current \[*I* ~K(M)~\] and *erg*-mediated K^+^ current \[*I* ~K(erg)~\]) or L-type Ca^2+^ current (*I* ~Ca,L~) in pituitary tumor (GH~3~) cells, a well-characterized and stable electrically excitable cell model.

2. Materials and Methods {#sec2}
========================

2.1. Cell culture {#sec2.1}
-----------------

Pituitary tumor (GH~3~) cells, acquired from the Bioresources Collection and Research Center (\[BCRC-60015\], <https://catalog.bcrc.firdi.org.tw/BcrcContent?bid=60015>\]; Hsinchu, Taiwan), were grown in Ham\'s F-12 medium supplemented with 2.5% (v/v) fetal calf serum, 15% (v/v) horse serum, and 2 mM L-glutamine, in a humidified atmosphere of 5% CO~2~ and 95% air at 37 °C. Subcultures were obtained by trypsinization (0.025% trypsin solution \[HyClone™\] containing 0.01% sodium *N*,*N*-diethyldithiocarbamate and EDTA). The experiments were conducted five days after cells were culture up to 60--80% confluence. The chemical, drugs, and solutions used were listed in **Supplementary Materials and Methods.**

2.2. Electrophysiological measurements {#sec2.2}
--------------------------------------

Immediately before the measurements were performed, cells were harvested with 1% trypsin/EDTA solution and an aliquot of cell suspension was carefully transferred to a home-made recording chamber which was firmly placed on the stage of an inverted DM-IL microscope (Leica; Major Products, New Taipei City, Taiwan). During the experiments, cells were adhered to the chamber bottom at room temperature (20--25 °C) in HEPES-buffered normal Tyrode\'s solution. To prepare the patch electrodes from Kimax-51 capillary tubes (\#34500; Kimble, Dogger, New Taipei City, Taiwan), either a PP-83 vertical puller (Narishige; Taiwan Instrument, Tainan, Taiwan) or a P-97 Flaming/Brown horizontal puller (Sutter: Taiwan Instrument, Tainan, Taiwan) was used; the tips were fire-polished with MF-83 microforge (Narishige). During the recordings, the electrodes, which bore resistances between 3 and 5 MΩ as filled with different internal solutions described above, were maneuvered by using an MX-4 manipulator (Narishige) and then finely operated by an MHW-3 hydraulic micromanipulator (Narishige). Standard patch-clamp recordings in the whole-cell configuration were undertaken by using either an RK-400 (Bio-Logic, Claix, France) or Axopatch-200B (Molecular Devices; Advance Biotech, New Taipei City, Taiwan) amplifier ([@bib47]). Giga-seals were generally achieved in an all-or-nothing fashion and resulted in a dramatic improvement in signal-to-noise ratio. Liquid junction potentials, which developed at electrode tip as there is a difference of the composition between the internal and the bath solutions, were nulled shortly prior to the seal formation. According to such potentials, the whole-cell data was corrected.

The signals of voltage and current tracings were simultaneously monitored and digitally stored at 10 kHz in an ASUSPRO-BU401LG computer (ASUS, Tainan, Taiwan) and data acquisition was achieved by pCLAMP 10.7 software (Molecular Devices). To minimize electrical noise, the current signals collected were low-pass filtered at 3 kHz. Through digital-to-analog conversion, the pCLAMP-generated voltage profiles including various types of rectangular or triangular waveforms were specifically designed and then delivered to evaluate either the current-voltage (*I--V*) relationships of the current, or voltage hysteresis of ionic currents specified. The details of Data analyses were displayed in **Supplementary Materials and Methods.**

2.3. Statistical analyses {#sec2.3}
-------------------------

The nonlinear Hill or Boltzmann equation was fit to experimental results either by using the Excel Solver (Microsoft, Redmond, WA), OriginPro 2016 (OriginLab; Schmidt, Taipei, Taiwan), or MathCad Prime 5.0 (Linksoft, New Taipei City, Taiwan). The activation, inactivation or deactivation time course of the current specified was fit either to single- or double-exponential function. The voltage- or current-clamp data are expressed as the mean ± S.E.M with sample sizes (n) indicating the cell number from which the data were carefully collected, and error bars were plotted as S.E.M. In the present study, as the assertions were made with respect to the variability of mean, the Student\'s *t*-test (for paired or unpaired samples), or one-way analysis of variance (ANOVA) followed by *post-hoc* Fisher\'s least-significant difference test was implemented for the statistical evaluation of differences among means. When the normality underlying ANOVA was assumed to be violated, the non-parametric Kruskal-Wallis test was used. All statistical calculations were performed with SPSS 17.0 (AsiaAnalytics, Taipei, Taiwan). Values of *P* \< 0.05 were statistically considered significant, unless otherwise stated.

3. Results {#sec3}
==========

3.1. Effect of PFD on hyperpolarization-activated cation current (I~h~) identified in pituitary GH~3~ cells {#sec3.1}
-----------------------------------------------------------------------------------------------------------

In initial experiments, the modification of *I* ~h~ caused by PFD in GH~3~ cells was evaluated. Cells were bathed in Ca^2+^-free Tyrode\'s solution, where Ca^2+^-activated K^+^ currents are mostly diminished, and the recording electrode was backfilled by using K^+^-containing isotonic solution. With the established whole-cell current recordings (i.e., membrane patch under the electrode was broken by gentle suction), the examined cells were voltage-clamped at the level of −40 mV, and a long-lasting membrane hyperpolarization to −110 mV was delivered. Under this experimental protocol, a large and slowly developing inward current activated in response to 2-s-long hyperpolarizing step was readily evoked, and regarded as an *I* ~h~ ([@bib21]; [@bib40]). After 1 min of continuous exposure of cell to PFD, a concentration-dependent decrease in the amplitude of *I* ~h~ was observed, in combination with a considerable slowing in activation and deactivation rate of the current ([Fig. 1](#fig1){ref-type="fig"} A). For example, the presence of 3 μM PFD produced a decline in current amplitude at the end of hyperpolarizing step from 73.5 ± 9.7 to 37.2 ± 4.2 pA (n = 9, *P* \< 0.05). Post the compound was washed out, current amplitude returned to 70.5 ± 8.5 pA (n = 9). Besides, apart from the depressed *I* ~h~ amplitude, the value of activation time constant (τ~act~) of the current, in response to sustained hyperpolarization, was evidently raised during exposure to the compound ([Fig. 1](#fig1){ref-type="fig"}A and B). For example, the application of 3 μM PFD to the bath was effective at increasing the τ~act~ value to 834 ± 54 ms (n = 9, *P* \< 0.05) from a control value of 576 ± 38 ms (n = 9).Fig. 1Effect of PFD on hyperpolarization-activated cation current (*I*~h~) measured from pituitary GH~3~ cells. **(A)** Representative *I*~h~ traces obtained in the absence (1) and presence of 1 μM PFD (2) or 3 μM PFD (3). The upper part shows the voltage protocol applied. **(B)** Summary bar graph showing the effect of PFD (1 and 3 μM) on the activation time constant (τ~act~) of *I*~h~ in response to step hyperpolarization applied from −40 to −110 mV with a duration of 2 s (mean ± S.E.M; n = 9 for each bar). \*, Significantly different from control (*P* \< 0.05). **(C)** Concentration-dependent inhibition of PFD on *I*~h~ in response to membrane hyperpolarization (mean ± S.E.M; n = 8 for each point). Current amplitude was taken at the end of 2-s hyperpolarizing pulse applied from −40 to −110 mV. The modified Hill equation detailed under **Materials and Methods** was reasonably fit to the experimental data (solid line).Fig. 1

The depressant effect of PFD with different concentration on *I* ~h~ elicited by 2-s-long sustained hyperpolarization was further examined. The concentration-dependent relationship of the inhibitory effect of this compound on *I* ~h~ amplitude in GH~3~ cells is illustrated in [Fig. 1](#fig1){ref-type="fig"}C. According to the Hill equation indicated under **Materials and Method**, the IC~50~ value of PFD which was needed for the inhibition of *I* ~h~ was thereafter calculated to be 3.65 μM with the Hill coefficient of 1.3.

3.2. Comparisons among the depressant effects of ivabradine, ivabradine plus PFD, zatebradine, zatebradine plus PFD on I~h~ amplitude {#sec3.2}
-------------------------------------------------------------------------------------------------------------------------------------

Next, whether the subsequent addition of PFD, but still in the continued presence of ivabradine or zatebradine, was able to perturb the block by ivabradine or zatebradine of *I* ~h~ inherently in GH~3~ cells was investigated. Ivabradine or zatebradine has been reported to decrease HCN-encoded currents effectively ([@bib9]; [@bib14]; [@bib31]). As shown in [Fig. 2](#fig2){ref-type="fig"} , subsequent application of PFD (3 μM), still in the presence of either ivabradine (1 μM) or zatebradine (1 μM), was capable of producing an additional decline in *I* ~h~ amplitude elicited by 2-s-long hyperpolarizing step. The experimental results obtained demonstrated that either ivabradine or zatebradine could act in concert with PFD to decrease *I* ~h~ amplitude, and could thus be interpreted to indicate that both inhibitory effects of ivabradine or zatebradine and that of PFD on *I* ~h~ amplitude appear to be additive in these cells.Fig. 2Comparisons among depressant effects of ivabradine (IVA), zatebradine (Zate), ivabradine plus PFD, and zatebradine plus PFD on *I*~h~ amplitude in GH~3~ cells (mean ± S.E.M; n = 8--9 for each bar). Current amplitudes were measured at the end of 2-s hyperpolarizing pulse applied from −40 mV abruptly to −110 mV. \*, Significantly different from control (*P* \< 0.05), ^†^, significantly different from ivabradine (1 μM) alone group (*P* \< 0.05), and ^‡^, significantly different from zatebradine (1 μM) alone group (*P* \< 0.05).Fig. 2

3.3. Effect of PFD on the I--V relationship of I~h~ in GH~3~ cells {#sec3.3}
------------------------------------------------------------------

The effect of PFD on *I* ~h~ at various levels of membrane potentials was next investigated. The *I* ~h~ was robustly evoked as the cell was hyperpolarized from −40 mV to a series of voltage steps ranging between −120 and −80 mV ([Fig. 3](#fig3){ref-type="fig"} A and B). The mean *I--V* relationships of *I* ~h~ with or without PFD were established and hence depicted in [Fig. 3](#fig3){ref-type="fig"}B. With whole-cell conductance of *I* ~h~ measured at the potentials ranging between −120 and −100 mV, the addition of 3 μM PFD was able to diminish the *I* ~h~ conductance from 4.62 ± 1.17 to 2.68 ± 0.09 nS (n = 8, *P* \< 0.05).Fig. 3Effect of PFD on mean current-voltage (*I--V*) relationships and the steady-state activation curve of *I*~h~ identified in GH~3~ cells. **(A)** The uppermost graph depicts the voltage profile applied, the potential traces labeled in different colors correspond with current traces obtained with or without PFD addition; the duration in each hyperpolarizing step is different for better illustrations. Below are representative *I*~h~ traces obtained in the absence (upper) and presence of 3 μM PFD (lower). **(B)** Mean *I--V* relationships of *I*~h~ amplitude in the absence (■) and presence (□) of 3 μM PFD (mean ± S.E.M; n = 8 for each point). Current amplitude was taken at the end of each hyperpolarizing step. **(C)** The steady-state activation curve of *I*~h~ obtained in the control (■) and during exposure to 3 μM PFD (○) detected in GH~3~ cells (mean ± S.E.M; n = 8 for each point). The continuous smooth lines overlaid on the data points show the least-squares fit to the Boltzmann equation indicated in **Materials and Methods**.Fig. 3

3.4. Perturbation of the steady-state activation curve of I~h~ caused by PFD {#sec3.4}
----------------------------------------------------------------------------

To further investigate the inhibitory effect of PFD on *I* ~h~ in GH~3~ cells, the possible changes induced by this compound on the steady-state activation curve of *I* ~h~ were studied. In these voltage-clamp experiments, a two-step voltage pulse was applied in situations where a 2-s conditioning pulse to various membrane potentials were delivered to precede the test pulse (2 s in duration) to −120 mV from −40 mV holding potential. [Fig. 3](#fig3){ref-type="fig"}C illustrates the relationship between the conditioning potentials versus the normalized amplitudes (I/I~max~) of *I* ~h~ obtained with or without PFD (3 μM). The data satisfactorily fitted to a Boltzmann function, as defined in **Materials and Methods**. In control, V~1/2~ = −85 ± 3 mV, q = 4.7 ± 0.4 *e* (i.e., elementary charges) (n = 8), whereas in the presence of 3 μM PFD, V~1/2~ = −96 ± 4 mV, q = 4.8 ± 0.4 *e* (n = 8). The data suggest that the exposure to PFD not only decreases the maximal conductance of *I* ~h~, but overly shifts the activation curve along with the voltage axis to the negative potential by roughly 11 mV; however, there was devoid of changes in the gating charge of the curve in its presence.

3.5. Effect of PFD on the voltage hysteresis elicited responding to triangular ramp pulse {#sec3.5}
-----------------------------------------------------------------------------------------

The voltage hysteresis of *I* ~h~ has been shown with an impact on electrical behaviors of AP firing ([@bib10]; [@bib28]). Therefore, it was explored whether a possible voltage hysteresis exists in *I* ~h~ measured from GH~3~ cells and how the presence of PFD modifies such hysteresis. In this experiment, a long-lasting inverted triangular ramp pulse with a duration of 2 s (i.e., ±0.1 V/s) was delivered in the whole-cell configuration. Of interest, as can be seen in [Fig. 4](#fig4){ref-type="fig"} A, the trajectories of *I* ~h~ elicited by the downsloping (i.e., hyperpolarized from −50 to −150 mV) and upsloping (i.e., depolarizing from −150 to −50 mV) ramp pulse as a function of time were overly distinguishable between these two limbs. The downsloping (forward) limb elicited current amplitude of the inverted triangular voltage ramp was lower than that by the upsloping (backward) limb, strongly indicating that there was a voltage hysteresis for this current in these cells. As the ramp speed was reduced, the hysteretic magnitude for *I* ~h~ became progressively increased. The degree of voltage hysteresis was quantified according to the difference in area under the curve in the forward (downsloping) and reverse (upsloping) direction, as denoted by the arrows in [Fig. 4](#fig4){ref-type="fig"}A. The data indicate that for *I* ~h~ in GH~3~ cells, the degree of voltage hysteresis increases with slower ramp speed, and that cell exposure to PFD leads to a substantial reduction in the amount of such hysteresis.Fig. 4Effect of PFD on the voltage hysteresis of *I*~h~ identified from GH~3~ cells. **(A)** Representative *I*~h~ traces in the absence and presence of 3 or 10 μM PFD. Current traces were elicited in response to 2-s long inverted triangular (i.e., downsloping and upsloping) ramp pulse applied between −50 and −150 mV. Inset denotes the inverted triangular ramp pulse given, and the dashed arrows denote the direction of *I*~h~ in which time passes. **(B)** Summary bar graph showing the effect of PFD (3 or 10 μM) and 10 μM PFD plus oxaliplatin (OXAL, 10 μM) on the Δarea of voltage hysteresis (mean ± S.E.M; n = 8 for each bar). \*, Significantly different from control (*P* \< 0.05) and ^†^, significantly different from PFD (10 μM) alone group (*P* \< 0.05).Fig. 4

In the experiments on PFD or PFD plus oxaliplatin on voltage hysteresis of *I* ~h~, a long-lasting inverted triangular ramp pulse with a duration of 2 s (i.e., ±0.1 V/s) was undertaken in the whole-cell configuration. [Fig. 4](#fig4){ref-type="fig"}B illustrates a summary of the data showing the effects of PFD and PFD plus oxaliplatin on the area (i.e., Δarea) under the curve between the forward and backward current traces. For example, the addition of PFD (3 μM) reduced the area up to 55%, elicited by the long-lasting inverted triangular voltage ramp. The PFD-mediated reduction in the magnitude of voltage hysteresis of *I* ~h~ could be significantly reversed by adding oxaliplatin (10 μM). Oxaliplatin, a chemotherapeutic antineoplastic agent, has been previously reported to activate *I* ~h~ ([@bib10]).

3.6. Failure of PFD to affect M-type K^+^ current (I~K(M)~) in GH~3~ cells {#sec3.6}
--------------------------------------------------------------------------

It was additionally evaluated whether the presence of PFD produces any effects on different types of K^+^ currents (e.g., *I* ~K(M)~) present in these cells. To measure *I* ~K(M)~, GH~3~ cells were bathed in high-K^+^, Ca^2+^-free solution with the recording pipette filled with K^+^-containing solution. The examined cell was voltage-clamped at −50 mV and sustained depolarization to −10 mV was applied ([@bib39]; [@bib41]). As illustrated in [Fig. 5](#fig5){ref-type="fig"} A and B, PFD at a concentration of 10 μM did not alone produce any effect on *I* ~K(M)~ responding to maintained depolarization applied from −50 to −10 mV. However, as 10 μM PFD was continually present, subsequent application of linopirdine (3 μM) noticeably decreased *I* ~h~ amplitude effectively, notwithstanding the ability of flupirtine (10 μM) alone to enhance current amplitude ([Fig. 5](#fig5){ref-type="fig"}B). Linopirdine can inhibit *I* ~K(M)~, while flupirtine has been reported to enhance *I* ~K(M)~ ([@bib18]; [@bib32]).Fig. 5Failure of PFD to modify M-type K^+^ current (*I*~K(M)~) identified in GH~3~ cells. In the current voltage-clamp experiments, cells were bathed in high-K^+^, Ca^2+^-free solution and the recording electrode was filled with K^+^-containing solution. **(A)** Representative *I*~K(M)~ traces in response to step depolarization (indicated in the upper part) were obtained in control (1), after cell exposure to 10 μM PFD (2), and after addition of 10 μM PFD plus 10 μM linopirdine (3). Arrowhead is the zero-current level and calibration mark shown at the right lower corner applied to all current traces. **(B)** Summary bar graph showing effect of PFD, PFD plus linopirdine, and flupirtine on *I*~K(M)~ amplitude in these cells (mean ± S.E.M; n = 9 for each bar). The *I*~K(M)~ amplitude was measured at the end of the depolarizing step from −50 to −10 mV. \*, Significantly different from control (*P* \< 0.05).Fig. 5

3.7. Inability of PFD to modify erg-mediated K^+^ current (I~K(erg)~) in GH~3~ cells {#sec3.7}
------------------------------------------------------------------------------------

In another set of experiments, whether another type of K^+^ current, namely *I* ~K(erg)~, would be subject to perturbations by PFD was also further examined. With cells bathed in high-K^+^, Ca^2+^-free solution and the pipette were filled with K^+^-containing solution ([@bib19]; [@bib41]). As shown in [Fig. 6](#fig6){ref-type="fig"} A and B, cell exposure to 10 μM PFD did not perturb the amplitude of deactivating *I* ~K(erg)~ elicited by membrane hyperpolarization as reported previously ([@bib41]). For example, as the cells were 1-s hyperpolarized to −90 mV from a holding potential of −10 mV, the peak amplitude of *I* ~K(erg)~ did not differ significantly between the absence and presence of 10 μM PFD (742 ± 43 pA \[control\] versus 739 ± 45 pA \[in the presence of 10 μM PFD\]; n = 9, *P* \> 0.05). Moreover, further application of BeKM-1 (1 μM), but still in the continued presence of PFD, was effective at decreasing *I* ~K(erg)~, as demonstrated by the significant reduction of *I* ~K(erg)~ amplitude to 328 ± 23 pA (n = 9, *P* \< 0.05). BeKm-1 is a scorpion toxin reported to suppress *I* ~K(erg)~ effectively in heart cells and to prolong QT interval in isolated rabbit heart ([@bib24]; [@bib34]). It is conceivable, therefore, that *I* ~K(M)~ or *I* ~K(erg)~ observed in GH~3~ cells is resistant to any modifications by PFD.Fig. 6Inability of PFD to alter the amplitude of *erg*-mediated K^+^ current (*I*~K(erg)~) in GH~3~ cells. The experiments were performed in situations where cells were bathed in high-K^+^, Ca^2+^-free solution and the pipette was backfilled with K^+^-containing solution. **(A)** Representative *I*~K(erg)~ traces obtained in the control (i.e., PFD was not present) (1), after addition of 10 μM PFD (2), or 10 μM PFD plus 1 μM BeKm-1 (3). Inset indicates the voltage protocol given, arrowhead is the zero-current level and calibration mark applies to all current traces. **(B)** Summary bar graph showing the effect of PFD and PFD plus BeKm-1 on the amplitude of deactivating *I*~K(erg)~ in these cells (mean ± S.E.M; n = 8 for each bar). The *I*~K(erg)~ amplitude was measured at the beginning of 1-s-long hyperpolarizing step applied from −10 to −90 mV. \*, Significantly different from control or PFD (10 μM) alone group (*P* \< 0.05).Fig. 6

3.8. Depressive effect of PFD on L-type Ca^2+^ current (I~Ca,L~) in GH~3~ cells {#sec3.8}
-------------------------------------------------------------------------------

Early studies have demonstrated the ability of PFD to augment the amplitude of *I* ~Ca,L~ in heart cells ([@bib35]). Therefore, it was further evaluated if PFD could modify the amplitude or gating of *I* ~Ca,L~ present in this lactotroph cell model. Previous reports have demonstrated the presence of L-type Ca^2+^ currents functionally expressed in pituitary GH~3~ cells ([@bib20]; [@bib27]). To achieve these objectives, in a separate set of whole-cell voltage-clamp experiments, cells were bathed in normal Tyrode\'s solution, which consists of 1.8 mM CaCl~2~, 10 mM tetraethylammonium chloride, and 1 μM tetrodotoxin, and the recording pipette was filled with a Cs^+^-containing solution. As can be seen in [Fig. 7](#fig7){ref-type="fig"} A, PFD (3 or 10 μM) decreased the peak amplitude of *I* ~Ca,L~ elicited by the 300-ms depolarizing pulse from −40 to 0 mV. However, no obvious changes were observed in the activation or inactivation time course of *I* ~Ca,L~ elicited responding to the abrupt step depolarization. Furthermore, as the clamp pulses of 300-ms duration from −40 mV to various membrane potentials were applied, the overall *I--V* relationship of peak *I* ~Ca,L~ seen with these cells virtually was not perturbed by the presence of PFD (10 μM) ([Fig. 7](#fig7){ref-type="fig"}B). As such, distinct from previous reports in heart cells ([@bib35]), the present results demonstrate that PFD exerts a depressant action of the peak *I* ~Ca,L~ in GH~3~ cells.Fig. 7Effect of PFD on L-type Ca^2+^ current (*I*~Ca,L~) in GH~3~ cells. The experiments were conducted in cells bathed in normal Tyrode\'s solution which contained 1.8 mM CaCl~2~, and the recording pipette was backfilled with Cs^+^-containing solution. **(A)** Representative *I*~Ca,L~ traces taken in the control (1), during the exposure to 3 μM PFD (2) or 10 μM PFD (3), and after washout of PFD (4). The inwardly directed *I*~Ca,L~ was evoked by the depolarizing pulse as indicated in the upper part. **(B)** Mean *I--V* relationships of peak *I*~Ca,L~ in the absence (■) and presence (□) of 10 μM PFD (mean ± S.E.M; n = 8 for each point). The current amplitude was measured at the beginning of each depolarizing pulse applied at various voltages. Note that the overall *I--V* relationship of peak *I*~Ca~ was not modified in the presence of PFD (10 μM).Fig. 7

3.9. Effect of PFD on the firing of spontaneous action potentials (APs) in GH~3~ cells {#sec3.9}
--------------------------------------------------------------------------------------

In a separate set of experiments, the model was switched to whole-cell current-clamp conditions where, as the cell was clamped at 0 current, any changes in membrane potential can be thereafter measured. During such potential recordings, cells were immersed in normal Tyrode\'s solution which consists of 1.8 mM CaCl~2~ and the pipette was filled with K^+^-containing internal solution. As depicted in [Fig. 8](#fig8){ref-type="fig"} A and B, cell exposure to PFD resulted in a progressive decline in the firing frequency of regenerative APs. For instance, the exposure to PFD at a concentration of 1 or 3 μM greatly decreased discharge rate of current-clamped cells to 1.07 ± 0.07 Hz (n = 9, *P* \< 0.05) or 0.74 ± 0.05 Hz (n = 9, *P* \< 0.05), respectively, from a control value of 1.45 ± 0.09 Hz (n = 9). Meanwhile, the presence of zatebradine (3 μM) alone was noted to decrease firing frequency effectively. Zatebradine has previously been reported to be an inhibitor of *I* ~h~ ([@bib31]; [@bib36]; [@bib45]). Therefore, it is conceivable from the current data that PFD-mediated modification in membrane potential tends to be intimately connected to its perturbations on both *I* ~h~ and *I* ~Ca,L~ detected above in these cells.Fig. 8Effect of PFD on regenerative actions potentials (APs) identified in GH~3~ cells. The set of current-clamp potential recordings in this and the following Figure was conducted in situations where cells were bathed in normal Tyrode\'s solution containing 1.8 mM CaCl~2~ and the recording electrode was filled with K^+^-containing solution. As whole-cell configuration was established, the recoding mode was rapidly switched to current-clamp conditions for measuring changes in membrane potential. **(A)** Representative potential traces obtained in the control (a) and during cell exposure to 1 μM PFD (b) or 3 μM PFD (c). **(B)** Summary bar graph showing the inhibitory effectiveness of PFD or zatebradine (Zate) on the firing frequency of regenerative APs in GH~3~ cells (mean ± S.E.M; n = 9 for each bar). \*, Significantly different from control (*P* \< 0.05).Fig. 8

3.10. Effect of PFD on sag voltage identified in GH~3~ cells {#sec3.10}
------------------------------------------------------------

In another stage of current-clamp recordings, the ability of PFD to induce perturbations on sag voltage was further investigated. The magnitude of such voltage responding to hyperpolarizing current injection has been reported linking to the emergence of *I* ~h~ ([@bib9]; [@bib13]). As depicted in [Fig. 9](#fig9){ref-type="fig"} A and B, under the current experimental conditions, when the whole-cell potential recordings were set up, the hyperpolarizing current injection at the amplitude of 25 pA was able to induce sag voltage (i.e., drop down to a lower level in the membrane potential applied by such hyperpolarizing current injection). The addition of chlorotoxin (1 μM), a blocker of Cl^−^ channels, was not found to exert any effect on the amplitude of sag voltage in response to hyperpolarizing current injection. On the other hand, as cells were exposed to PFD, the amplitude of sag voltage was decreased. For example, the addition of 1 μM PFD caused a reduction in the sag-voltage amplitude from 55 ± 13 to 36 ± 11 mV (n = 8, *P* \< 0.05). Therefore, the depression of sag voltage caused by PFD can be ascribed in large part to its inhibitory effect on the amplitude and gating of *I* ~h~ detected above in these cells.Fig. 9Effect of PFD on sag voltage identified in GH~3~ cells. As the whole-cell recordings were achieved, the experiment was rapidly switched to current-clamp configuration with 2-s hyperpolarizing current stimuli. **(A)** Potential traces obtained in the absence (1) and presence (2) of 1 mM PFD. The upper part is the current stimulus applied. **(B)** Summary bar graph showing inhibitory effect of PFD on the amplitude of sag voltage in these cells (mean ± S.E.M; n = 8). \*, Significantly different from control (*P* \< 0.05) and ^†^, significantly from 1 μM PFD alone group (*P* \< 0.05).Fig. 9

4. Discussion {#sec4}
=============

The *I* ~h~ of pituitary GH~3~ cells demonstrated in the present investigation can be observed following the 2-s-long hyperpolarizing pulse applied from −40 mV to the voltages more negative to −80 mV, and the currents were increased in both current amplitude and activation in response to more hyperpolarizing potentials ([@bib9]; [@bib14]; [@bib21]; [@bib40]). The forward and backward amplitudes of this current elicited by long-lasting inverted triangular ramp pulse were also noted to be distinct, strongly reflecting the presence of voltage-dependent hysteresis fo *I* ~h~ ([@bib6]; [@bib28]). This major ion conductance inherently present in GH~3~ lactotrophs was identified as an *I* ~h~ or *I* ~f~ current ([@bib9]; [@bib40]). Specifically, this study shows for the first time the effectiveness of PFD in depressing the amplitude of *I* ~h~ in a concentration - and voltage-dependent fashion.

In this study, the block by PFD on *I* ~h~ in GH~3~ cells are not strictly limited to its inhibition of the current amplitude. Concomitantly, as cells were exposed to PFD, the time course of *I* ~h~ activation and deactivation, in response to sustained membrane hyperpolarization, apparently became slower. The presence of this compound was found to produce a decrease in *I* ~h~ activation in a concentration- and time-dependent manner. The results thus prompted us to reflect that blocking of *I* ~h~ by PFD inherently is not instantaneous, but develops with time after the HCN channel opened and subsequently produces a slowing in current activation. In other words, the PFD molecule tends to represent a higher affinity for the open state in the HCN channel; consequently, the transition from closed to open state turns out to be slower during cell exposure to PFD. It is thus possible that PFD or its structurally related compounds bind to the open state of the channel and/or block a prolonged channel opening.

The steady-state activation curve of *I* ~h~ detected in this study was shifted along the voltage axis toward a negative voltage in the presence of PFD. However, failure of PFD to change the gating charge of the current in situations where the transmembrane electrical field can be crossed during current activation, suggests that PFD action on the HCN channel might consist in opening the gate, not interfering with the region that senses the transmembrane potential. Nonetheless, the sensitivity of electrically excitable cells to PFD could rely not simply on the PFD concentrations given, but also the pre-existing level of the resting potential, the firing pattern of APs, or their combinations, assuming the magnitude of *I* ~h~ is present in the cells examined.

Voltage-dependent hysteresis of *I* ~h~ is considered to serve a role in influencing the overall behaviors of electrically excitable cells including GH~3~ cells. In accordance with previous observations (([@bib6]; [@bib10]; [@bib28]), the *I* ~h~ natively in GH~3~ cells has been described either to undergo a hysteretic perturbation in its voltage dependence, or to produce a shift of ion-channel mode in which the voltage sensitivity in gating charge movement of the current is dependent on the previous state of the HCN channel involved ([@bib16]; [@bib28]). In the present study, we also investigated the perturbations of PFD on non-equilibrium property of *I* ~h~ consistently observed in GH~3~ cells. In this regard, because of a reduction in Δarea of hysteretic loop between forward and backward limp of the inverted triangular ramp pulse, the experimental data suggest that the presence of this compound is capable of diminishing such hysteresis entailed in the voltage-dependent elicitation of *I* ~h~.

The PFD concentration required for the half-maximal inhibition of *I* ~h~ detected in this study was optimally determined to be 3.65 μM, a value which was within the clinically applied doses reported previously. For example, following intravenous administration of PFD, plasma concentration of this compound was previously reported to range between 0.1 and 10 μg/ml (i.e., 0.54 and 54 μM) ([@bib44]). Alternatively, recent investigations reported the utilization of drug-delivery vehicles (e.g., nanoparticles) to facilitate specific delivery of PFD to the target organs ([@bib22]; [@bib29]). In this scenario, the observed effects by PFD presented herein may achieve the concentration of clinical requirements, so that maneuvers are implemented to mitigate the systemic toxicity.

Ivabradine or zatebradine, known to inhibit HCN-encoded currents, have been previously reported to reduce diastolic dysfunction and later to ameliorate cardiac fibrosis in animal models ([@bib7]; [@bib15]). In our study, subsequent addition of PFD, still in the continued presence of this compound, can further depress *I* ~h~ amplitude. As such, the inhibitory effect of ivabradine (or zabebradine) and PFD on *I* ~h~ detected in GH~3~ cells could be additive. The elucidation whether the specific pharmacological interaction between the compounds is additive or even synergistic would require a more specific approach (i.e. isobolographic assessment), which is beyond the scope of the present study. Alternatively, further application of TGF-β (1 μM) had no modifications on PFD-mediated depression of *I* ~h~ (data not shown). A previous study revealed the *I* ~h~ functionally expressed in vascular smooth myocytes ([@bib17]). A caveolin-binding domain existing in the HCN4 channels has been also reported to mediate the functional interaction with caveolin proteins ([@bib5]). Therefore, to what extent PFD-mediated depression of *I* ~h~ participates in its antifibrotic activity remained to be further resolved. Whether PFD-mediated block of *I* ~h~ potentially contributes to its cardioprotective action described previously ([@bib2]; [@bib15]; [@bib30]) also needs further detailed investigations.

It is important to mention, from the present observations, that unlike its depressant effectiveness on *I* ~Ca,L~, block of *I* ~h~ caused by PFD tends to be not instantaneous, but develops with time after the HCN channels become overly opened upon sustained membrane hyperpolarization, thereby producing a conceivable increase in τ~act~ value detected from whole-cell current activation. In the presence of this compound, deactivating current of *I* ~h~ was also notably observed to exhibit a blunted peak followed by a slowing in the decay, reflecting that the closing (i.e., deactivating process) of channels virtually became slower by unbinding of the PFD molecule. PFD or its structurally similar compounds may hence be an intriguing tool to probe HCNx channels in the structural and functional perspectives, given that the pore region of the channel protein to which they bind appears to be of particular relevance for an open-channel blockade.

The present observations revealed the effectiveness of PFD on the decline in the firing frequency of spontaneous APs observed under current-clamp potential measurements. The amplitude of sag voltage elicited by 2-s hyperpolarizing current stimuli was also decreased in its presence. The inhibition by PFD of *I* ~h~ amplitude and gating may confer its effectiveness on different cellular functions (e.g., stimulus-secretion coupling) in various types of electrically excitable cells ([@bib26]; [@bib42]; [@bib48]). Whether similar findings occur in different types of native cells *in vivo* still remains to be further delineated.

It is also important to emphasize that the treatment with PFD has been described to enhance the peak amplitude of *I* ~Ca,L~ in heart cells ([@bib35]). However, in the present study, vastly different from the depressant action of PFD on *I* ~h~, the addition of this compound was able to decrease the peak *I* ~Ca,L~ detected in GH~3~ cells. Moreover, neither activation nor inactivation time course of the current by abrupt membrane depolarization presumably was not modified. A previous study has indeed reported that quercetin, a bioflavonoid, could either increase or decrease the amplitude of *I* ~Ca,L~ in different types of electrically excitable cells ([@bib46]). Nonetheless, in combination with the depression of *I* ~h~, PFD-mediated depression of *I* ~Ca,L~ might also contribute to its effectiveness in altering functional activities of endocrine or neuroendocrine cells ([@bib26]), despite inability of PFD to alter the amplitude of *I* ~K(M)~ or *I* ~K(erg)~. However, how PFD-perturbed changes on *I* ~h~ or other ionic currents demonstrated here could be linked to its pathological or morphological changes (e.g., fibrosis) remained to be further studied.

5. Conclusions {#sec5}
==============

Taken together, these results suggest that PDF is able to produce a decrease in *I* ~h~ activation in a concentration-dependent manner. Also, the substance presents the characteristic of opening HCN channel and counteracting a prolonged channel opening. Our findings on GH~3~ cells shed light on the evidence that PFD perturbs specific ionic currents which may be linked to additional effects, potentially useful for therapeutic application, when elicited on different excitable cells.
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